gamer456148

KZR Fib Retracement: Next Target $5 + Big Potential

Short
NASDAQ:KZR   Kezar Life Sciences, Inc.
Please keep in mind not to take anything I say seriously, as this is of opinion basis and not face value. That being said, let us get to the analysis. I believe through the Fibonacci retracement, we can look at a short target of $5 for the next trend analysis goal of Kezar life sciences. Kezar had a huge decline in price over the past year, but the strong support may out do the negative bids and resistance. They are also expected to go to the next stage of their drug development and testing pipeline before the end of the year (according to their site). It is too early to call a long on this, but given the potential and current support, I am at least calling a short for this with a profit target of $5 being hit soon. It could even pass a $15 threshold in price before the end of the year, but a long call is still too early.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.